A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis

201944 citationsJournal Articlehybrid Open Access

Authors

Anthony J. Bleyer · Wake Forest University

Vincent Scavo · Lutheran Medical Group

Samuel E. Wilson · University of California, Irvine

Barry J. Browne · Sharp HealthCare Foundation

Brian L. Ferris · Northwest Eye Surgeons

C. Keith Ozaki · Brigham and Women's Hospital

Timmy Lee ·

Abstract

Vonapanitase treatment did not significantly improve primary patency but was associated with increased secondary patency and use for hemodialysis. Further research is needed to evaluate these end points.

Topics & Keywords

Central Venous Catheters and Hemodialysis Vascular Malformations Diagnosis and Treatment Dialysis and Renal Disease Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Vascular Surgery

Volume 69, Issue 2, pp. 507-515

DOI: 10.1016/j.jvs.2018.04.068

Field-Weighted Citation Impact: 9.24